## Abstract Metoclopramide (MCP) is a dopamine receptor antagonist and serotonine receptor agonist widely used as an antiemetic and gastric prokinetic drug. In addition MCP is a reversible inhibitor of cholinesterases from human central nervous system and blood. MCP may have a cholinesterase protec
Inhibition of human erythrocyte and plasma cholinesterases by methamidophos
β Scribed by Casey P. Robinson; Donald Beiergrohslein
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 150 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0260-437X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Methamidophos (O, Sβdimethyl phosphoramidothioate) inhibition of human erythrocyte and plasma cholinesterase was studied in vitro. The pseudoβbiomolecular rate constant of inhibition was 3.14 Β± 0.22 Γ 10^3^ M^β1^ min^β1^ for erythrocyte cholinesterase and 1.85 Β± 0.01 Γ 10^3^ M^β1^ min^β1^ for plasma cholinesterase. Thus methamidophos, although quite toxic to mammals, is a slow, rather nonβselective inhibitor of human cholinesterases, as was also observed previously in rats.
π SIMILAR VOLUMES
## Abstract Metoclopramide (MCP) is a dopamine receptor antagonist and serotonin receptor agonist widely used as an antiemetic and gastric prokinetic drug. In addition MCP is a reversible inhibitor of cholinesterases from human central nervous system and blood. Metoclopramide may have a cholinester
The effect of galanthamine (GAL) and its 2 major metabolites on human cholinesterases has been explored. Epigalanthamine, a diastereomer of GAL, was 130-times less potent in vitro in its effect on acetylcholinesterase (AChE) in erythrocytes than the parent compound, and it did not differ significant